These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

58 related items for PubMed ID: 2321450

  • 1. Metastatic breast carcinoma in pleural fluid. Correlation of morphology with estrogen receptor activity and morphology of the primary carcinoma.
    Wiley EL, Von Roenn J.
    Acta Cytol; 1990; 34(2):169-74. PubMed ID: 2321450
    [Abstract] [Full Text] [Related]

  • 2. Impact of metastatic estrogen receptor and progesterone receptor status on survival.
    Lower EE, Glass EL, Bradley DA, Blau R, Heffelfinger S.
    Breast Cancer Res Treat; 2005 Mar; 90(1):65-70. PubMed ID: 15770528
    [Abstract] [Full Text] [Related]

  • 3. Mammaglobin and CRxA-01 in pleural effusion cytology: potential utility of distinguishing metastatic breast carcinomas from other cytokeratin 7-positive/cytokeratin 20-negative carcinomas.
    Ciampa A, Fanger G, Khan A, Rock KL, Xu B.
    Cancer; 2004 Dec 25; 102(6):368-72. PubMed ID: 15558786
    [Abstract] [Full Text] [Related]

  • 4. In vitro clonogenic growth and metastatic potential of human operable breast cancer.
    Nomura Y, Tashiro H, Hisamatsu K.
    Cancer Res; 1989 Oct 01; 49(19):5288-93. PubMed ID: 2766296
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Estrogen receptor-negative, progesterone receptor-positive breast carcinoma: poor clinical outcome.
    Keshgegian AA, Cnaan A.
    Arch Pathol Lab Med; 1996 Oct 01; 120(10):970-3. PubMed ID: 12046611
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. HER-2 expression and response to tamoxifen in estrogen receptor-positive breast cancer: a Southwest Oncology Group Study.
    Elledge RM, Green S, Ciocca D, Pugh R, Allred DC, Clark GM, Hill J, Ravdin P, O'Sullivan J, Martino S, Osborne CK.
    Clin Cancer Res; 1998 Jan 01; 4(1):7-12. PubMed ID: 9516946
    [Abstract] [Full Text] [Related]

  • 9. Altered expression and activation of the nerve growth factor receptors TrkA and p75 provide the first evidence of tumor progression to effusion in breast carcinoma.
    Davidson B, Reich R, Lazarovici P, Ann Flørenes V, Nielsen S, Nesland JM.
    Breast Cancer Res Treat; 2004 Jan 01; 83(2):119-28. PubMed ID: 14997042
    [Abstract] [Full Text] [Related]

  • 10. The cytologic diagnosis of malignant neoplasms in pleural and peritoneal effusions.
    Sears D, Hajdu SI.
    Acta Cytol; 1987 Jan 01; 31(2):85-97. PubMed ID: 3469856
    [Abstract] [Full Text] [Related]

  • 11. Comparison of triple-negative and estrogen receptor-positive/progesterone receptor-positive/HER2-negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucose/positron emission tomography imaging parameters: a potentially useful method for disease characterization.
    Basu S, Chen W, Tchou J, Mavi A, Cermik T, Czerniecki B, Schnall M, Alavi A.
    Cancer; 2008 Mar 01; 112(5):995-1000. PubMed ID: 18098228
    [Abstract] [Full Text] [Related]

  • 12. Different prognostic value of cytokeratin-19 mRNA positive circulating tumor cells according to estrogen receptor and HER2 status in early-stage breast cancer.
    Ignatiadis M, Xenidis N, Perraki M, Apostolaki S, Politaki E, Kafousi M, Stathopoulos EN, Stathopoulou A, Lianidou E, Chlouverakis G, Sotiriou C, Georgoulias V, Mavroudis D.
    J Clin Oncol; 2007 Nov 20; 25(33):5194-202. PubMed ID: 17954712
    [Abstract] [Full Text] [Related]

  • 13. Selective reduction of estrogen receptor (ER) positive breast cancer occurrence by estrogen receptor modulators supports etiological distinction between ER positive and ER negative breast cancers.
    Kurbel S.
    Med Hypotheses; 2005 Nov 20; 64(6):1182-7. PubMed ID: 15823713
    [Abstract] [Full Text] [Related]

  • 14. Biologic and clinical characteristics of breast cancer with single hormone receptor positive phenotype.
    Rakha EA, El-Sayed ME, Green AR, Paish EC, Powe DG, Gee J, Nicholson RI, Lee AH, Robertson JF, Ellis IO.
    J Clin Oncol; 2007 Oct 20; 25(30):4772-8. PubMed ID: 17876012
    [Abstract] [Full Text] [Related]

  • 15. Expression of bcl-2 protein predicts efficacy of adjuvant treatments in operable node-positive breast cancer.
    Gasparini G, Barbareschi M, Doglioni C, Palma PD, Mauri FA, Boracchi P, Bevilacqua P, Caffo O, Morelli L, Verderio P.
    Clin Cancer Res; 1995 Feb 20; 1(2):189-98. PubMed ID: 9815973
    [Abstract] [Full Text] [Related]

  • 16. [Estrogen and progesterone receptors of primary breast carcinoma and their axillary lymph node metastases--immunohistochemical investigations of routine formalin-fixed paraffin-embedded tissue].
    Schulze MH, Buchmann J.
    Zentralbl Gynakol; 2000 Feb 20; 122(2):92-5. PubMed ID: 10721188
    [Abstract] [Full Text] [Related]

  • 17. Morphologic and clinical aspects of estrogen receptors in carcinoma of the breast.
    Kern WH.
    Surg Gynecol Obstet; 1979 Feb 20; 148(2):240-2. PubMed ID: 217114
    [Abstract] [Full Text] [Related]

  • 18. Estrogen and progesterone receptors in neoplastic cells of metastatic pleural effusion of breast carcinoma before and after tamoxifen therapy. Correlation with the clinical response.
    Di Lorenzo D, Zaniboni A, Simoncini E, Marpicati P, Montini E, Alghisi A, Gorni F, Marini G.
    Chemioterapia; 1986 Aug 20; 5(4):232-6. PubMed ID: 3769044
    [Abstract] [Full Text] [Related]

  • 19. Bcl-2 immunoreactivity in breast carcinoma correlates with hormone receptor positivity.
    Bhargava V, Kell DL, van de Rijn M, Warnke RA.
    Am J Pathol; 1994 Sep 20; 145(3):535-40. PubMed ID: 8080038
    [Abstract] [Full Text] [Related]

  • 20. Recruitment with high physiological doses of estradiol preceding chemotherapy: flow cytometric and therapeutic results in women with locally advanced breast cancers--a Southwest Oncology Group study.
    Fabian CJ, Kimler BF, McKittrick R, Park CH, Lin F, Krishnan L, Jewell WR, Osborne CK, Martino S, Hutchins LF.
    Cancer Res; 1994 Oct 15; 54(20):5357-62. PubMed ID: 7923165
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.